Filing metadata

Accession number
0001104659-21-116048
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Sep 15, 2021
Reporting period
Sep 14, 2021
Description
Insider transaction

Explore SEC Filings Hub